Riskpilot← Back to searchSign inGet full accessTermino C 11354 AB
ABDissolvedOrg 5564979705Medical specialists activities · NACE 8622Est. 19941 employees
Revenue 2023
SEK 65K
-6% vs 2022
EBITDA margin
-15.9%
-245% vs 2022
Equity ratio
43.7%
Financial strength
Net profit 2023
SEK 9K
+558% vs 2022
| Revenue | SEK 65K | -6% |
| EBITDA | SEK -10K | -245% |
| Net profit | SEK 9K | +558% |
| Total assets | SEK 322K | -7% |
| Equity | SEK 141K | +7% |
| Employees | 1 | — |
Legal name
Termino C 11354 AB
Org number
5564979705
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 november 1994
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 398 | 75 | 28 | 69 | 65 |
| Staff expenses | — | — | — | — | −5 |
| EBITDA | 244 | −40 | −34 | 7 | −10 |
| Depreciation & amort. | −0 | −0 | −3 | −7 | −7 |
| EBIT | 244 | −40 | −37 | −0 | −18 |
| Net financials | −1 | — | — | — | 1 |
| Profit before tax | 180 | −15 | 165 | −0 | 13 |
| Tax | −43 | −0 | −37 | −2 | −4 |
| Net profit | 137 | −15 | 128 | −2 | 9 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 767 | 547 | 485 | 347 | 322 |
| Equity | 295 | 130 | 258 | 131 | 141 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 51 | 21 | 32 | 22 | 17 |
| Total debt | 51 | 21 | 32 | 22 | 17 |
EBITDA margin
-15.9%
This company
15.8%
Market median
-201% vs market
20192023
Equity ratio
43.7%
This company
38.2%
Market median
+14% vs market
20192023
Return on equity
6.6%
This company
18.4%
Market median
-64% vs market
20192023
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
20192023
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20192023
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
OÅ Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Deputy Board Member | 2020 – 2024 | |
| Chairman | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 11354 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ola Åke Axel Asplund | Audit | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Eva Birgitta Morén | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Stefan Morén | Chairman | 0 companies |
| Kristian Morén | Board of Directors | 0 companies |